This observation aligns with emerging research in humans exploring how GLP-1 medications may influence brain pathways related to reward and consumption behaviors, such as alcohol consumption
Inflammation and irritability: Hormone imbalances can increase systemic inflammation, which has been linked to brain fog, irritability, and even depressive symptoms
Relaxation and immunity enhancement effects of aminobutyric acid (GABA) administration in humans
Appetite suppression, gastrointestinal side effects, and rapid weight changes can be clinically destabilizing for individuals with current or past eating disorders
A standard U-100 insulin syringe (1.0 mL / 100 units) is used for compounded GLP-1 vials
By modulating many pathways (such as p53, FOXO, Nrf2, NF-B), among other things, it can participate in the control of oxidative stress, inflammatory reactions, apoptosis, and the breakdown of energy